This article discusses the pervasive use of race-based clinical algorithms in medicine, specifically focusing on how the eGFR equation for kidney function has been adjusted based on race. The article details the resistance and opposition faced by those advocating to remove race from these algorithms, highlighting the generational and institutional challenges in implementing change. The article also covers the impact of these changes, including the reconsideration of transplant lists and the reevaluation of kidney function assessments. Ultimately, the article emphasizes the importance of addressing racial disparities in medicine and the need for continued efforts to promote health equity.
Source link